New born screening has evolved from a simple blood and urine screening test to a more comprehensive and complex screening system which is capable of detecting over 50 different conditions New born screening is a public health program conducted where new born babies are screened and identified with rare but some serious medical conditions (genetic, hormonal or metabolic conditions) which can affect normal growth of the new born but are treatable. New born screening include various tests such as hearing test, urine test, dry blood test and others that are undertaken during initial few hours or days of an infant’s life. Recently, conditions such as congenital hypothyroidism, phenylketonuria (PKU), cystic fibrosis (CF), and about 22 other metabolic conditions can be diagnosed through new born screening tests that affect fat metabolism or protein. New born screening tests measure a different types of markers present in infant’s blood that can either increase or decrease, if an infant has certain diseases

Market Dynamics

Key companies in market are collaborating with government organizations, which will drive market growth in forecast period. For instance, in February 2020, Severe Combined Immunodeficiency (SCID) screening programme for Public Health England selected PerkinElmer, Inc. to be provider of newborn screening test. PerkinElmer, Inc. will provide EnLite Neonatal TREC Kit and VICTOR EnLite instrument to Public Health England to screen new borns at three out of six sites being part of the programme.

In addition, the unmet medical needs and rise in demand for personalized healthcare are expected to drive the market growth during the forecast period. Unmet medical needs especially in disease areas such as amino acid disorders, organic acid disorders, fatty acid oxidation disorders, Lysosomal storage disorders in emerging economies like India, China and Brazil. For instance, according to Centers for Disease Control and Prevention 2019 report, in the U.S. infant mortality rate was 5.7 deaths per 1,000 live births in 2018. These deaths are due to diseases like amino acid disorder, organic acid disorders, fatty acid oxidation disorder and lysosomal storage disorder Addressing these problems may provide significant growth in global new born screening market during forecast period.

Key features of the study

• This report provides an in-depth analysis of the global new born screening market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global new born screening market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Bio-rad Laboratories, Inc., Medtronic Plc, Masimo Corporation, Natus Medical, Inc., PerkinElmer, Inc., ZenTec S.A., Trivitron Pvt Ltd., Waters Technology Corporation, Danaher Corporation, Baebies, Inc., Parseq Lab Co. Ltd, Chromesystem Instruments, and RECIPIE Chemicals + Instruments GmbH
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global new born screening market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global new born screening market

Market Segmentation

• By Product
  • Instruments
  • Assay Kits
  • Reagents
• By Test Type
  • Dry Blood Spot Test
  • Cardiac Test
  • Hearing Test
  • Urine Test
  • Others
• By Application
  • Phenylketonuria
  • Critical Congenital Cardiac Disease
  • Maple Syrup Urine Disease
  • Hearing Disability
  • Sickle Cell Disease
  • Others
• By End User
  • Hospital
  • Maternity and Specialty Clinics
  • Diagnostic Centers
• By Regions
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Agilent Technologies, Inc.
  • Bio-rad laboratories, Inc.
  • Medtronic Plc
  • Masimo Corporation
  • Natus Medical Inc.
  • Perkin Elmer, Inc
  • ZenTec S.A.
  • Trivitron Healthcare Pvt Ltd
  • Waters Technologies Corporation
  • Danaher Corporation
  • Baebies, Inc.
  • Parseq Lab Co. Ltd
  • Chromesystem Instruments and Chemicals GmbH
  • RECIPE  Chemicals+ Instrument GmbH